Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Multicenter Randomized Trial to Evaluate the Efficacy of Bioven, Manufactured by Biopharma Plasma, LLC, in Complex Therapy of Patients With Pneumonia Induced by COVID-19 / SARS-CoV-2

NCT04500067 is registered in ClinicalTrials.gov with Biopharma Plasma LLC as lead sponsor.

NCT NCT04500067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04500067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Multicenter Randomized Trial to Evaluate the Efficacy of Bioven, Manufactured by Biopharma Plasma, LLC, in Complex Therapy of Patients With Pneumonia Induced by COVID-19 / SARS-CoV-2
Lead sponsor
Biopharma Plasma LLC
Phase
Phase 3
Overall status
Completed
Start date
May 7, 2020
Completion date
September 15, 2020
Enrollment
76 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, pneumonia